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ABSTRACT
Verocytotoxin-producing Escherichia coli (VTEC) O157:H7 is a predominant cause of haemorrhagic 
colitis (HC) and haemolytic uraemic syndrome (HUS) in humans. To assess the role of dogs as a possible source 
of transmission of VTEC O157:H7 to humans, the faeces of diarrhoeic (31) and non-diarrhoeic (63) dogs were 
examined for the presence of the organism. Escherichia coli O157:H7 was isolated from 22 (23.4%) out of 94 
samples examined. The organism was detected in 5 (16.1%) out of 31 diarrhoeic faeces and 17 (26.9%) out of 
63 non-diarrhoeic faeces, but the difference was not statistically signifi cant (P>0.05). All the E. coli O157:H7 
isolates produced one or both of verocytotoxin 1 and 2 (VT1 and VT2). Verocytotoxin 1 (VT1) was detected in 
10 (45.5%) out of 22 isolates, VT2 in 8 (36.4%), while both toxin types were detected in four (18.2%) isolates. 
Sixteen (72.7%) out of 22 isolates were resistant to at least three antimicrobials from different classes, while 18 
distinct antimicrobial resistance patterns were observed among the isolates. The isolates showed resistance to 
ampicillin (86.4%), chloramphenicol (36.4%), ciprofl oxacin (4.5%), gentamicin (18.2%), kanamycin (68.2%), 
nalidixic acid (22.7%), neomycin (40.9%), norfl oxacin (9.1%), streptomycin (63.6%), sulphamethoxazole/
trimethoprim (63.6%) and tetracycline (77.3%). The present study showed that diarrhoeic and non-diarrhoeic 
dogs may serve as potential sources of multi-drug resistant VTEC O157:H7 transmissible to humans.
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Introduction 
Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 is the dominant verocytotoxin 
producing E. coli strain that is known to be associated with both outbreak and sporadic 
cases of human diseases ranging from uncomplicated diarrhoea to haemorrhagic colitis, 
characterized by passage of bloody stool and abdominal cramps, with little or no fever 
(PATON and PATON, 1998; RANGEL et al., 2005; SUGIYAMA et al., 2005). In 5 to 10% of 
cases, infection may lead to haemolytic uraemic syndrome (HUS) defi ned by a triad of 
features of acute renal failure, thrombocytopaenia and microangiopathic haemolytic 
uraemia, which is the leading cause of acute renal failure in children and the elderly 
(PATON and PATON, 1998; TZIPORI et al., 2004).
Asymptomatic animals, especially ruminants, are the reservoir host of E. coli 
O157:H7. The organism is resident in the gastrointestinal tract of carrier animals and 
is shed intermittently in the faeces. The organism has been detected in the faeces of 
apparently healthy cattle, sheep, goats, pigs, dogs, bats and avian species (BEUTIN et 
al., 1999; DIPINETO et al., 2006; OJO et al., 2010a; OJO et al., 2010b; ITALIA et al., 2012). 
Transmission of E. coli O157:H7 to humans occurs through consumption of contaminated 
food substances or by contact with infected persons, carrier animals and contaminated 
environments (RILEY et al., 1983; PARRY and SALMON, 1998; CRUMP et al., 2003).
Production of verocytotoxins (VT), also called shiga toxins (ST), is the major 
determinant of the virulence of E. coli O157:H7 (PATON and PATON, 1998). Two major 
types of VT (VT1 and VT2) have been recognized (PATON and PATON, 1998). The two 
toxins are genetically and immunologically distinct, with only about 55 to 60% genetic 
and amino acid sequence relatedness (LEE et al., 2007). However, their mechanism of 
action is essentially the same. They inhibit cellular protein synthesis, leading to the death 
of affected cells (PATON and PATON, 1998). The toxins have a profound effect on the 
endothelial cells of blood vessels, thus causing endothelial damage (PATON and PATON, 
1998). The toxins affect many organs of the body and contribute signifi cantly to the 
clinical manifestation of E. coli O157:H7 infections (PATON and PATON, 1998; TZIPORI 
et al., 2004). 
Although there are several reports on the occurrence of E. coli O157:H7 in food 
animals (ZSCHÖCK et al., 2000; OJO et al., 2010b), there is paucity of information on the 
possible roles of companion animals in the zoonotic transmission of E. coli O157:H7 to 
humans. Dogs are important human companions and the close contact that exists between 
humans and dogs may facilitate exchange of pathogens between them. In order to assess 
the role of dogs as possible reservoirs of E. coli O157:H7, the present study investigated 
the prevalence of verocytotoxin producing E. coli O157:H7 in the faeces of diarrhoeic 
and non-diarrhoeic dogs, and determined the antimicrobial susceptibility of the isolates.
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Materials and methods
Sample collection. Using sterile swabs, faecal samples were collected directly from 
the rectum of diarrhoeic (31) and non-diarrhoeic (63) dogs attending two veterinary 
hospitals in Abeokuta, Nigeria. Dogs visiting the clinics for various reasons were sampled 
with consideration for the presence or absence of diarrhoea in every case. Samples were 
collected from the patients before commencement of treatment. The samples were 
properly labelled and transported to the laboratory with ice-packs for microbiological 
analysis.
Isolation and identifi cation of Escherichia coli O157:H7. Each sample was pre-
enriched by inoculating a faecal swab into 9 mL of sterile Tryptone Soya Broth (TSB) 
(CM0129, Oxoid®, Basingstoke, UK) in universal bottles and incubated at 37 OC for 4 hours. 
One millilitre of the pre-enrichment culture was then transferred into 9 mL of modifi ed 
Tryptone Soya Broth (mTSB) (CM0989, Oxoid®, Basingstoke, UK) supplemented with 
vancomycin (8 μg/mL), cefsulodin (10 μg/mL) and cefi xime (0.05 μg/mL) (VCC selective 
supplement SR0190, Oxoid®, Basingstoke, UK) for the selective enrichment required for 
the isolation of E. coli O157:H7. The selective enrichment cultures were incubated at 37 
OC for 18 to 24 hours. A loopful of mTSB selective enrichment culture was inoculated onto 
sorbitol MacConkey agar (SMAC) with 5-bromo-4-chloro-3-indolyl-β-D-glucuronide 
(BCIG) (CM0981, Oxoid®), into which cefi xime tellurite supplement (SR0172, Oxoid®, 
Basingstoke, UK) was incorporated. The SMAC-BCIG agar plates were incubated at 
37 OC for 18-24 hours. After incubation, the plates were examined for bacterial growth. 
Pale yellow colonies on SMAC-BCIG plates were selected for further identifi cation tests. 
Selected colonies were tested for oxidase and catalase production. The isolates were also 
characterized biochemically, using a commercially available biochemical test kit for the 
identifi cation of Gram-negative, oxidase negative bacilli (Microbact GNB 24E, Oxoid®, 
Basingstoke, UK) and the results were interpreted using the accompanying computer 
software package (Oxoid Microbact® 2000 version 2.03). Isolates identifi ed as E. coli 
were identifi ed serologically using an E. coli O157 latex test kit (DR0620M, Oxoid®, 
Basingstoke, UK) and E. coli H7 antiserum (Difco®, USA) by a slide agglutination test.
Antimicrobial susceptibility testing. Isolates identifi ed as E. coli O157:H7 were tested 
for susceptibility to 11 antimicrobial agents including ampicillin (10 μg), chloramphenicol 
(30 μg), ciprofl oxacin (5 μg), gentamicin (10 μg), kanamycin (30 μg), nalidixic acid (30 
g), neomycin (30 μg), norfl oxacin (10 μg), streptomycin (10 μg), sulphamethoxazole/
trimethoprim (23.75/1.25 μg) and tetracycline (30 μg). Susceptibility was determined 
by the standard Kirby-Bauer disk diffusion method (ANONYM., 2012a) and the result 
interpreted in accordance with the recommended guidelines (ANONYM., 2012b). 
Resistance to neomycin was determined using the breakpoint reported by SAYAH et al. 
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(2005) because the Clinical and Laboratory Standards Institute guidelines (ANONYM., 
2012b) do not provide a breakpoint for E. coli susceptibility to neomycin.
Detection of verocytotoxin production by E. coli O157:H7 isolates. Production of 
verocytotoxin 1 and 2 by E. coli O157:H7 isolates was detected by the reverse passive 
latex agglutination test, using a VTEC-RPLA toxin detection kit (Oxoid®, TD0960). 
Escherichia coli O157:H7 isolates were inoculated onto Brain Heart Infusion Agar 
slopes (BHIA, Oxoid®, CM 0375) and incubated at 37 OC for 18 hours. Verocytotoxin was 
extracted from the bacterial culture by transferring part of the culture with a wire-loop 
into 1 mL of 0.85% sodium chloride solution containing polymyxin B, at a concentration 
of 5000 units per millilitre. The bacterial suspension was incubated for 30 minutes at 
37 OC with periodic shaking at 5 minute intervals. After incubation, the suspension was 
fi ltered using a low protein binding membrane fi lter (Corning®, Germany) with 0.2 μm 
pore size. The fi ltrate was collected and used for toxin detection assay by reversed passive 
latex agglutination. 
Using a micropipette, 25 μL of diluents (supplied with the toxin detection kit) was 
dispensed into 24 wells in three rows (eight wells in each row) of V-bottom microtitre 
plate. With 25 μL of the fi ltrate under test, a 1:2 serial dilution (double dilution) was 
made in each row from the fi rst well to the seventh. The eighth well was left containing 
only the diluents. After this, 25 μL of latex coated VT1 rabbit antiserum was added to 
all the eight wells in the fi rst row, latex VT2 to the wells in second row and control 
latex to the wells in third row. The contents of the wells were mixed by gentle agitation 
to avoid spillage. The microtitre plate was covered and the reaction allowed tocontinue 
undisturbed on a laboratory bench at room temperature for 20-24 hours. Each reaction well 
was then examined visually against a black background for agglutination. The degrees of 
agglutination in the wells were scored and interpreted according to the manufacturer’s 
instruction.
Statistical analysis. Data were expressed in absolute numbers and percentages. 
Proportions were compared using Chi-square test at P<0.05 probability level, using the 
Statistical Package for Social Sciences (SPSS) version 16 software (ANONYM., 2007). 
Results
Prevalence of E. coli O157:H7 in the faeces of dogs. Escherichia coli O157:H7 was 
isolated from 22 (23.4%) out of 94 samples examined. The prevalence of E. coli O157 
in diarrhoeic dogs was 15.8% in puppies and 16.7% in adults. Among the non-diarrhoeic 
dogs, the prevalence was 27.3% in puppies and 26.8% in adult dogs (Table 1). Overall, 5 
(16.1%) out of 31 diarrhoeic faeces and 17 (26.9%) out of 63 non-diarrhoeic faeces were 
positive for E. coli O157:H7. There was no signifi cant difference (P>0.05) between the 
prevalence of E. coli O157:H7 in the faeces of diarrhoeic and non-diarrhoeic dogs. Also, 
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the observed differences in the prevalence of the organism in puppies and adult dogs were 
not statistically signifi cant (P>0.05).
Verocytotoxin production by E. coli O157:H7. All the E. coli O157:H7 isolates 
produced one or both verocytotoxins. Verocytotoxin 1 was detected in 10 (45.5%) out of 
22 isolates, VT2 was detected in 8 (36.4%), while both toxin types were detected in four 
(18.2%) (Table 2).
Table 1. Prevalence of Escherichia coli O157:H7 in the faeces of dogs in Abeokuta, Nigeria
Nature of sample Number sampled Number (%) positive
Diarrhoeic faeces
Puppies 19 3 (15.8)
Adults 12 2 (16.7)
Subtotal 31 5 (16.1)
Non-diarrhoeic faeces
Puppies 22 6 (27.3)
Adults 41 11 (26.8)
Subtotal 63 17 (26.9)
Overall total 94 22 (23.4)
 Table 2. Verocytotoxin production in Escherichia coli O157:H7 isolates from the faeces of dogs 
in Abeokuta, Nigeria
Sources of isolate (number tested)
Number of isolate producing verocytotoxins
VT1 VT2 VT1/VT2
Diarrhoeic faeces of puppies (3) 1 1 1
Diarrhoeic faeces of adults dogs (2) 0 2 0
Subtotal (5) 1 3 1
Non-diarrhoeic faeces of puppies (6) 3 2 1
Non-diarrhoeic faeces of adults dogs (11) 6 3 2
Subtotal (17) 9 5 3
Overall total (22) 10 8 4
Antimicrobial resistance in E. coli O157:H7. The E. coli O157:H7 isolates showed 
resistance to ampicillin (86.4%), chloramphenicol (36.4%), ciprofl oxacin (4.5%), 
gentamicin (18.2%), kanamycin (68.2%), nalidixic acid (22.7%), neomycin (40.9%), 
norfl oxacin (9.1%), streptomycin (63.6%), sulphamethoxazole/trimethoprim (63.6%) 
and tetracycline (77.3%) (Table 3). Sixteen (72.7%) out of 22 isolates were resistant to at 
least three antimicrobials from different classes, while 18 distinct antimicrobial resistance 
patterns were observed among the isolates (Table 4). 
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Table 3. Antimicrobial resistance in Escherichia coli O157:H7 isolates from the faeces of dogs 




Number (%) of resistant 
isolates
Ampicillin (10) ≤13 19 (86.4)
Chloramphenicol (30) ≤12 8 (36.4)
Ciprofl oxacin (5) ≤15 1 (4.5)
Gentamicin (10) ≤12 4 (18.2)
Kanamycin (30) ≤13 15 (68.2)
Nalidixic acid (30) ≤13 5 (22.7)
Neomycin (30) ≤12 9 (40.9)
Norfl oxacin (10) ≤12 2 (9.1)




Tetracycline ≤11 17 (77.3)
Table 4. Antimicrobial resistance patterns of Escherichia coli O157:H7 the faeces of dogs
Resistance 
groups Resistance patterns
Number and Source of isolates
Diarrhoeic faeces Non-diarrheic faeces
Puppies Adult dogs Puppies Adult dogs
1 Chl - - - 1
2 AmpKan - - - 2
3 AmpTet - 1 - 1
4 AmpNeoTet 1 - - -
5 CipNalStr - - - 1
6 AmpKanStrTet - - 1 -
7  ChlNorSulTet - - - 1
8 AmpKanStrSulTet - - 1 1
9 AmpNeoStrSulTet 1 - - -
10 AmpChlKanNeoSul - 1 - -
11 AmpGenKanStrSulTet - - - 1
12 AmpChlKanStrSulTet - - 1 1
13 AmpKanNalNeoStrSulTet - - - 1
14 AmpGenKanNalNeoStrSulTet - - - 1
15 AmpChlGenKanNeoStrSulTet - - 1 -
16 AmpChlKanNalNeoStrSulTet - - 1 -
17 AmpGenKanNeoNorStrSulTet - - 1 -
18 AmpChlKanNalNeoStrSulTet 1 - - -
Total 3 2 6 11
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Discussion
In the present study, verocytotoxin-producing E. coli (VTEC) O157:H7 was detected 
in the faeces of diarrhoeic and non-diarrhoeic dogs. Moreover, there was no signifi cant 
difference in the prevalence of the organism in the faeces of diarrhoeic and non-diarrhoeic 
dogs. Indeed, the prevalence of VTEC O157:H7 was slightly higher in non-diarrhoeic 
dogs than in diarrhoeic dogs, suggesting that VTEC O157:H7 may not be a primary 
cause of diarrhoea in dogs. A previous study has shown that oral administration of VTEC 
O157:H7, isolated from the clinical condition in humans, failed to induce either signs of 
intestinal colonization or invasion of internal organs in dogs (KUSUNOKI et al., 2004). 
However, E. coli O157:H7 was recovered from the faeces of inoculated dogs. Findings 
from the present study also suggest that the presence of diarrhoea did not increase the 
possibility of VTEC O157:H7 detection. In addition, age did not signifi cantly infl uence 
the shedding of VTEC O157:H7 in dogs. 
Verocytotoxin production was detected in all the E. coli O157:H7 isolates from 
dogs in this study. Previous studies have reported the detection of VTEC in dogs in both 
diarrhoeic and non-diarrhoeic dogs (HAMMERMUELLER et al., 1995; BEUTIN, 1999; 
SANCAK et al., 2004). In a review by BEUTIN (1999), the rate of VTEC detection was up 
to 12.3 in healthy dogs and 8.8 in diarrhoeic dogs. Similarly, HAMMERMUELLER et al. 
(1995) reported that 17.2 of diarrhoeic dogs were positive for VTEC while SANCAK et al. 
(2004) detected VTEC in the faeces of 28.1 of dogs. However, the VTEC strains were not 
identifi ed by serotyping. The specifi c detection of VTEC O157:H7 in dogs as reported in 
the present study is higher than the 4.0% isolation rate in Argentina (BENTANCOR et al., 
2007) and the 0.16% in Japan (KATAOKA et al., 2010). The higher prevalence of VTEC 
O157:H7 as observed in the present study might be due to the possibly higher exposure 
of the dogs examined in the present study to the organism. It has been suggested that dogs 
may acquire VTEC O157:H7 from ruminants, which are considered to be the principal 
reservoirs of the organism (HOGG et al., 2009). In the study area, dog-owners are in the 
habit of feeding their dogs undercooked beef, restaurant leftovers, as well as foetuses 
and offal obtained from slaughter cattle at abattoirs. These foods might be contaminated 
with E. coli O157:H7 (PRADEL et al., 2000; KHANNA et al., 2008; OJO et al., 2010b) and 
hence serve as vehicles for its transmission to dogs. Besides, dogs might wander from 
home and have direct access to slaughter-houses and meat markets where they scavenge 
for remnants of fresh meat (ADEYEMO, 2002) and thus may acquire E. coli O157:H7 
in the process. Wandering dogs may also acquire the organism from a contaminated 
environment. In the study area, ruminants (cattle, sheep and goats) are reared under 
the extensive and semi-intensive system of management and are a common sight on 
the street. These animals litter the environment with their dung and this contributes to 
environmental E. coli O157:H7 contamination.
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The presence of VTEC O157:H7 in dogs, as revealed by the present study, showed 
that dogs could be important as reservoirs of VTEC O157:H7 and may be potential sources 
of zoonotic transmission to humans. The close interaction that exists between dogs and 
humans may facilitate easy transfer of VTEC O157:H7 from dogs to humans. Outbreaks 
of clinical VTEC O157:H7 infections in humans have been linked to close association 
with asymptomatic carrier dogs (TREVENA et al., 1996; HOGG et al., 2009). Members of 
dog-keeping households, veterinarians and dog handlers are at risk of acquiring VTEC 
O157:H7 from dogs. However, dogs are not considered the true maintenance host of 
VTEC O157:H7 (HOGG et al., 2009). Following acquisition of VTEC O57:H7, dogs 
shed the organism transiently in faeces, but may pass the infection to humans and also 
contaminate the environment during the period of shedding.
The present study revealed a high rate of antimicrobial resistance among VTEC 
O157:H7 isolated from dogs. The majority of the isolates demonstrated multidrug resistance 
to three or more drugs from different antimicrobial classes. There was high resistance 
(above 60%) to fi rst-line antimicrobials (ampicillin, tetracycline, sulphamethoxazole/
trimethoprim and streptomycin), commonly administered empirically in the treatment of 
bacterial infections in dogs. The rate of resistance to the new generation antimicrobials, 
such as ciprofl oxacin and norfl oxacin, was very low (below 10%). These resistant strains 
may cause refractory zoonotic infection in humans. The high rate of antimicrobial usage in 
small animal practice and the feeding of dogs with animal products containing high levels 
of antimicrobial residues may contribute to the emergence of antimicrobial resistance 
in bacteria recovered from dogs (PRESCOTT et al., 2002; DIPEOLU and ALONGE, 2002). 
The development of antimicrobial resistance in VTEC O157:H7 may also be due to 
the acquisition of conjugative resistance plasmids from other resistant bacteria micro-
fl ora resident within the gastrointestinal tract of the host animal (ZHAO et al., 2001). 
The problem of antimicrobial resistance in the treatment of human infections has been 
associated with zoonotic transfer of resistant bacterial strains from animals to humans 
(BYWATER et al., 2004). 
In conclusion, the present study showed that VTEC O157:H7 may not be an important 
aetiological agent of diarrhoea in dogs. However, diarrhoeic and non-diarrhoeic dogs 
of all ages may serve as potential sources of multi-drug resistant VTEC O157:H7 
transmissible to humans. Adherence to the principles of personal hygiene may minimise 
human exposure to VTEC O157:H7 from dogs. 
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SAŽETAK
Verotoksični sojevi bakterije Escherichia coli (VTEC) O157:H7 pretežito uzrokuju hemoragijski kolitis 
(HC) i hemolitičko-uremijski sindrom (HUS) u ljudi. Radi procjene uloge pasa kao mogućeg  izvora prijenosa 
VTEC O157:H7 na ljude, pretraženi su uzorci njihova proljeva (31) i normalno formiranog fecesa (63) na 
prisutnost te bakterije. Escherichia coli O157:H7 bila je izdvojena iz 22 (23,4%) od 94 pretražena uzorka. 
Bila je dokazana u 5 (16,1%) od 31 uzorka proljeva  i 17 (26,9%) od 63 uzorka normalno formiranog izmeta. 
Nije bila ustanovljena statistički značajna razlika (P>0,05). Svi izolati bakterije E. coli O157:H7 proizvodili 
su jedan ili oba verotoksina: 1 i 2 (VT1 i VT2). Verotoksin 1 bio je dokazan  u 10 (45,5%) od  22 izolata, 
VT2 u osam (36,4%), dok su oba tipa toksina bila dokazana u četiri (18,2%) izolata. Šesnaest (72,7%) od 22 
izolata bilo je otporno na najmanje tri antimikrobne tvari različitih skupina. Među izolatima je bilo ustanovljeno 
18 različitih obrazaca otpornosti na antimikrobne tvari. Izolati su pokazivali otpornost na ampicilin (86,4%), 
kloramfenikol (36,4%), ciprofl oksacin (4,5%), gentamicin (18,2%), kanamicin (68,2%), nalidiksičnu kiselinu 
(22,7%), neomicin (40,9%), norfl oksacin (9,1%), streptomicin (63,6%), sulfametoksazol/trimetoprim (63,6%) i 
tetraciklin (77,3%). Istraživanje je pokazalo da psi s proljevom i bez proljeva mogu biti izvor multiplorezistentne 
VTEC O157:H7 za ljude. 
Ključne riječi: pas, E. coli O157:H7, izmet, višestruka otpornost, verotoksin________________________________________________________________________________________
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